The impact of anti-TNF therapy on CD4+ and CD8+ cell subsets in ankylosing spondylitis
OBJECTIVES: Ankylosing spondylitis (AS) is a chronic, progressive immune-mediated inflammatory disease, driven primarily by Th1 and Th17 cells. Anti-TNF therapies are successfully used in AS to achieve and maintain remission. However, their influence on the composition of T-cell subsets is not clea...
Elmentve itt :
| Szerzők: | |
|---|---|
| Dokumentumtípus: | Cikk |
| Megjelent: |
Karger
2018
|
| Sorozat: | PATHOBIOLOGY
85 No. 3 |
| doi: | 10.1159/000484250 |
| mtmt: | 3317419 |
| Online Access: | http://publicatio.bibl.u-szeged.hu/13063 |